• Earlier this week, Jefferies initiated coverage on XP Inc. with a positive view, while XP announced a cash dividend, treasury share retirement, and a new share repurchase program aimed at returning capital to shareholders.
• Together, the upbeat analyst coverage and shareholder-friendly capital actions highlight how XP is positioning itself within Brazil’s competitive wealth management landscape.
• We’ll now look at how XP’s new dividend and buyback plans may shape its broader investment narrative for long-term investors.

These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

What Is XP's Investment Narrative?

To own XP, you really need to buy into Brazil’s wealth management story and XP’s role at the center of it, with double‑digit revenue and earnings growth, high margins and returns on equity that stand out against many global capital markets peers. The recent Jefferies initiation and the stock’s strong one‑year total return reinforce that many professional investors already view XP as mispriced relative to consensus targets around US$23.86, but the core short‑term catalysts remain largely the same: execution on earnings, asset gathering and the pace of share repurchases. The new dividend and expanded buyback framework add a clearer capital‑return angle and could support the shares if XP continues to trade at a discount, though they do not change the fundamental risks tied to competition, regulation and Brazil’s macro backdrop.

However, one key Brazil‑specific risk here is easy to underestimate. XP's shares have been on the rise but are still potentially undervalued by 12%. Find out what it's worth.

Exploring Other Perspectives

Five Simply Wall St Community fair value views span roughly US$17.95 to US$23.86 per share, underscoring how far opinions can diverge. Set that against XP’s stronger recent price performance and capital‑return push, and you can see why many people are revisiting what could drive or pressure future returns.

Explore 5 other fair value estimates on XP - why the stock might be worth as much as 20% more than the current price!

Build Your Own XP Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your XP research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free XP research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate XP's overall financial health at a glance.

Curious About Other Options?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• We've found 12 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
• Trump's oil boom is here - pipelines are primed to profit. Discover the 22 US stocks riding the wave.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.